PSCH · NASDAQ · ETF
Invesco S&P SmallCap Health Care ETF (PSCH) Price, Holdings & Fees
Invesco S&P SmallCap Health Care ETF (PSCH) closed at $187.56 on Oct 9, 2026, down 0.73% from the previous close of $188.94.
Share price, past year
1Y +12.59%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $187.56 |
| Sep 30, 2026 | $181.22 |
| Aug 31, 2026 | $173.37 |
| Jul 31, 2026 | $159.48 |
| Jun 30, 2026 | $162.58 |
| May 29, 2026 | $167.34 |
| Apr 30, 2026 | $170.59 |
| Mar 31, 2026 | $161.62 |
| Feb 27, 2026 | $159.32 |
| Jan 30, 2026 | $149.96 |
| Dec 31, 2025 | $147.02 |
| Nov 28, 2025 | $153.69 |
| Oct 31, 2025 | $166.34 |
Key statistics
- Expense ratio
- 0.29%
- as of Dec 31, 2025
- Net assets
- $131.4M
- as of May 31, 2026
- Holdings
- 81
- as of May 31, 2026
- 52-week range
- $144.87 – $188.94
Invesco S&P SmallCap Health Care ETF's expense ratio is 0.29%: $29.00 a year on $10,000 invested.
Holdings
Invesco S&P SmallCap Health Care ETF held 81 investments worth $131.36M as of May 31, 2026. Its largest holding was Invesco Private Prime Fund, at 21.48% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | Invesco Private Prime Fund | 21.48% | $28.21M |
| 2 | Invesco Private Government Fund | 8.27% | $10.86M |
| 3 | Molina Healthcare, Inc. | 4.77% | $6.26M |
| 4 | BrightSpring Health Services, Inc. | 4.35% | $5.72M |
| 5 | Krystal Biotech, Inc. | 4.25% | $5.59M |
| 6 | Alkermes PLC | 3.71% | $4.88M |
| 7 | Corcept Therapeutics Inc. | 3.47% | $4.56M |
| 8 | Glaukos Corp. | 3.17% | $4.16M |
| 9 | PTC Therapeutics, Inc. | 3.16% | $4.15M |
| 10 | Protagonist Therapeutics, Inc. | 3.12% | $4.10M |
| 11 | Teleflex Inc. | 3.03% | $3.98M |
| 12 | TG Therapeutics, Inc. | 2.75% | $3.61M |
| 13 | Ligand Pharmaceuticals Inc. | 2.43% | $3.20M |
| 14 | Indivior Pharmaceuticals, Inc. | 2.40% | $3.15M |
| 15 | RadNet, Inc. | 2.06% | $2.71M |
| 16 | Merit Medical Systems, Inc. | 1.99% | $2.62M |
| 17 | Veracyte, Inc. | 1.95% | $2.57M |
| 18 | Catalyst Pharmaceuticals, Inc. | 1.92% | $2.53M |
| 19 | Organon & Co. | 1.85% | $2.43M |
| 20 | ICU Medical, Inc. | 1.78% | $2.34M |
| 21 | Integer Holdings Corp. | 1.67% | $2.19M |
| 22 | Concentra Group Holdings Parent, Inc. | 1.58% | $2.08M |
| 23 | Acadia Pharmaceuticals Inc. | 1.45% | $1.90M |
| 24 | Supernus Pharmaceuticals, Inc. | 1.41% | $1.85M |
| 25 | Privia Health Group, Inc. | 1.33% | $1.74M |
Top 25 of 81 holdings, as of May 31, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 99.93% |
| Cash and short-term investments | 29.79% |
| Country | % of fund |
|---|---|
| United States | 125.20% |
| Ireland | 4.53% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to May 31, 2026, Invesco S&P SmallCap Health Care ETF's total return was +4.00%, as reported to the SEC.
| Month | Total return |
|---|---|
| May 31, 2026 | +1.15% |
| Apr 30, 2026 | +8.33% |
| Mar 31, 2026 | −5.09% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- Invesco S&P SmallCap Health Care ETF
- Ticker
- PSCH
- Exchange
- NASDAQ
- Fund type
- ETF
- Trust
- Invesco Exchange-Traded Fund Trust II
- SEC series ID
- S000028299
- SEC CIK
- 0001378872
- Fractional shares
- Yes
Recent SEC filings
- Jul 28, 2026
- 485BPOSProspectus updateSep 15, 2026
- Jul 6, 2026
- May 4, 2026
- 485BPOSProspectus updateMar 6, 2026
- 485BPOSProspectus updateFeb 26, 2026
- 485BPOSProspectus updateFeb 20, 2026
- 485BPOSProspectus updateFeb 18, 2026
Shareholder reports and prospectuses are filed by Invesco Exchange-Traded Fund Trust II, the trust behind Invesco S&P SmallCap Health Care ETF, and cover all of its funds.
Frequently asked questions
What is PSCH's price?
Invesco S&P SmallCap Health Care ETF (PSCH) closed at $187.56 on Oct 9, 2026, down 0.73% from the previous close of $188.94.
What is PSCH's expense ratio?
Invesco S&P SmallCap Health Care ETF's expense ratio is 0.29%: $29.00 a year on $10,000 invested.
What does PSCH hold?
Invesco S&P SmallCap Health Care ETF held 81 investments worth $131.36M as of May 31, 2026. Its largest holding was Invesco Private Prime Fund, at 21.48% of the fund. Its five largest holdings were Invesco Private Prime Fund, Invesco Private Government Fund, Molina Healthcare, Inc., BrightSpring Health Services, Inc., Krystal Biotech, Inc..
How has PSCH performed?
Over the 3 months to May 31, 2026, Invesco S&P SmallCap Health Care ETF's total return was +4.00%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of May 31, 2026 (filed Jul 28, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Dec 31, 2025. Prices are generated sample data for development. Data sources and disclosures